KRYS
Companies
NASDAQ
Krystal Biotech Inc.
Health Care
$132.09
-$24.57 (-15.68%)
Price Chart
Overview
About KRYS
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
Market Cap
$4.7B
Volume
42.3M
Avg. Volume
38.2M
P/E Ratio
28.291454
Dividend Yield
0.00%
Employees
208.0
Company Information
Latest News for KRYS
Risk & Correlation Analysis
Market Correlation
1.19
Moderate Correlation
Volatility
High (0.49)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, KRYS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$4.7B
Volume42.3M
P/E Ratio28.29
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 19, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025